Literature DB >> 3666059

Properties of in vitro nonenzymatically glycated plasma fibrinogens.

S Krantz1, M Lober, M Thiele, E Teuscher.   

Abstract

Nonenzymatic glycation of fibrinogen is species independent and depends only on the glucose concentration in the incubation mixture under selected in vitro conditions. An increased fibrin monomer aggregation in the presence of Ca2+ ions and a decreased proteolytic susceptibility of nonenzymatically glycated fibrinogens may favour the development of thrombophilic states. Blocking of lysine residues as well as restricted conformational changes induced by glucose attachment may be responsible for these effects. Fibrin stabilization by factor XIII is not impaired by nonenzymatic glycation of fibrinogen. Attachment of aortic endothelial cells to fibrin films from glycated fibrinogens is diminished. This phenomenon may be the result of blocked plasminogen activator binding sites in fibrin by nonenzymatic glycation. These effects may contribute in vivo to the accumulation of fibrin in those tissues most frequently affected by diabetic complications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3666059     DOI: 10.1055/s-0029-1210670

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  3 in total

1.  Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.

Authors:  Marlien Pieters; Namukolo Covic; Francois H van der Westhuizen; Chandrasekaran Nagaswami; Yelena Baras; Du Toit Loots; Johann C Jerling; Dale Elgar; Kathryn S Edmondson; Danie G van Zyl; Paul Rheeder; John W Weisel
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

2.  Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.

Authors:  Judith J de Vries; Charlotte J M Snoek; Dingeman C Rijken; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-09       Impact factor: 8.311

3.  N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes.

Authors:  Bin Wang; Tak Yee Aw; Karen Y Stokes
Journal:  Redox Biol       Date:  2017-09-20       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.